• Privia Health CFO David Mountcastle sold 8,385 common shares in transactions dated May 1 and May 4.
• Sales were executed at USD 25.03 and USD 25 per share, following option exercises at USD 2 per share.
• Direct holdings ended unchanged at 214,847 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Privia Health Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001858396-26-000009), on May 05, 2026, and is solely responsible for the information contained therein.